Cargando…
Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
Cancer immunotherapy has recently emerged as a powerful tool for the treatment of diverse advanced malignancies. In particular, therapeutic application of immune checkpoint modulators, such as anti-CTLA4 or anti-PD-1/PD-L1 antibodies, have shown efficacy in a broad range of malignant diseases. Altho...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714868/ https://www.ncbi.nlm.nih.gov/pubmed/29250075 http://dx.doi.org/10.3389/fimmu.2017.01702 |